IM Cannabis Corp. (IMCC)
3.20
-0.21
(-6.16%)
USD |
NASDAQ |
Aug 31, 15:09
IM Cannabis Debt to Equity Ratio : -2.497 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.497 |
| March 31, 2026 | -2.962 |
| December 31, 2025 | -4.361 |
| September 30, 2025 | 4.432 |
| June 30, 2025 | 4.443 |
| March 31, 2025 | 2.964 |
| December 31, 2024 | 3.436 |
| September 30, 2024 | 2.63 |
| June 30, 2024 | 2.228 |
| March 31, 2024 | 1.423 |
| December 31, 2023 | 0.9525 |
| September 30, 2023 | 0.6094 |
| June 30, 2023 | 0.635 |
| March 31, 2023 | 0.4229 |
| December 31, 2022 | 0.5092 |
| September 30, 2022 | 0.1427 |
| June 30, 2022 | 0.2029 |
| March 31, 2022 | 0.1772 |
| December 31, 2021 | 0.1454 |
| September 30, 2021 | 0.1162 |
| June 30, 2021 | 0.105 |
| March 31, 2021 | 0.1044 |
| December 31, 2020 | 0.0892 |
| September 30, 2020 | 0.0362 |
| June 30, 2020 | 0.0395 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0432 |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.0043 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.0026 |
| October 31, 2017 | 0.0026 |
| July 31, 2017 | 0.0004 |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | 0.0004 |
| January 31, 2015 | 0.0016 |
| October 31, 2014 | 0.0016 |
| July 31, 2014 | 0.0016 |
| April 30, 2014 | 0.009 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | 2.176 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 0.2676 |
| Purple Biotech Ltd. | 0.0109 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 17.40M |
| Total Liabilities (Quarterly) | 21.37M |
| Shareholders Equity (Quarterly) | -3.904M |
| Current Ratio | 0.5552 |
| Net Debt Paydown Yield | 0.29% |